AstraZeneca, Bristol-Myers Squibb in merger talks: FT report

AZN -0.24% LLY +0.02% ABBV +1.12% GSK -1.02% XBI +1.14%

1. 1AstraZeneca (AZN) and Bristol-Myers Squibb (BMY) have been discussing a merger over the past several months
2. 2The combined enterprise value would be about $400 billion, versus AZN's market cap of roughly $264 billion and BMY's of about $133 billion
3. 3The Financial Times warned that negotiations could be delayed or fall through, and both companies declined to comment

Source Bloomberg +12 · View original ↗

Today's 5 AI picks, all free

Nothing hidden: past picks and how they did against the S&P 500.

See today's picks →